Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of biologically active compounds. For more information on the areas of research that MCRE publishes, please see the Instructions for Authors.

  • Offers prompt publication of experimental achievements in drug design, drug discovery and mechanisms of action
  • Covers chemical biological relationships, and correlations of structure with mode of action
  • Increases understanding of biochemical interactions
  • 97% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

  • Longqin Hu
Publishing model
Hybrid (Transformative Journal). Learn about publishing Open Access with us

Journal metrics

1.783 (2019)
Impact factor
1.608 (2019)
Five year impact factor
16 days
Submission to first decision
88 days
Submission to acceptance
256,906 (2020)

Latest articles

This journal has 77 open access articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Call for Papers: a Special Issue in honor of Prof. Gary Grunewald

    Picture of Gary GrunewaldWe are delighted to announce a special issue of Medicinal Chemistry Research honoring Prof. Grunewald, a respected teacher and a well-known and highly regarded medicinal chemist. The special issue will be guest edited by Dr. Michael Wolfe and Dr. Moorthy Palanki. We would like to invite you to submit a review or research article to this special issue under the broad theme of drug design and discovery. We aim for submission by March 1, 2021 and publication of the special issue in mid 2021.

    Prof. Grunewald received his BS in Chemistry and Bachelor in Pharmacy from Washington State University in 1960 and his Ph.D in Physical Organic Chemistry working with Prof. Howard Zimmerman at University of Wisconsin, Madison in 1966. He then joined the faculty at the University of Kansas in the Department of Medicinal Chemistry where he had been until his retirement in 2018. He served as the department chair in 1994-2003 and received the Higuchi/Simons Research Achievement Award for research excellence in the biomedical sciences at the University of Kansas. He has served the Medicinal Chemistry Division of ACS in various capacities including as Vice Chair (1993), Chair (1994), Councilor (1999-2001), and as a general chair of the 27th National Medicinal Chemistry Symposium in 2000. He was inducted to the ACS Division of Medicinal Chemistry Hall of Fame in 2006 and elected as a Fellow of both the AAPS (2006) and AAAS (1992). He trained over 100 undergraduate and graduate students in his laboratory over the decades, and his trainees went on to successful careers of their own in academia, industry, and government.

  • Call for Papers: a Special Issue in honor of Prof. Robert Vince

    Picture of Prof. Robert Vince © Photo by Rohit Singh, published with permissionMedicinal Chemistry Research is pleased to announce a special issue in honor of Prof. Robert Vince on the occasion of his 80th birthday. 

    The special issue will be guest edited by Dr. Zhengqiang Wang and Dr. David Ferguson. Interested authors are invited to submit a review paper or research article to this special issue under the broad theme of drug design and discovery. The deadline for submission is 1 November, 2020.

  • New Editor-in-Chief

    We are pleased to announce that Longqin Hu, Ph.D. is the new Editor-in-Chief of Medicinal Chemistry Research, commencing January 1st, 2020.

View all updates


Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles starting 1997
  • Downloadable in PDF format
  • Subscription expires 12/31/2021

About this journal

Electronic ISSN
Print ISSN
Abstracted and indexed in
  2. BFI List
  4. Biological Abstracts
  5. CAB Abstracts
  6. CNKI
  7. Chemical Abstracts Service (CAS)
  8. Chimica
  9. Current Contents/ Life Sciences
  10. Dimensions
  11. EBSCO Discovery Service
  12. EMBASE
  13. Google Scholar
  14. INIS Atomindex
  15. Institute of Scientific and Technical Information of China
  16. Japanese Science and Technology Agency (JST)
  17. Journal Citation Reports/Science Edition
  18. Meta
  19. Naver
  20. Norwegian Register for Scientific Journals and Series
  21. OCLC WorldCat Discovery Service
  22. ProQuest Central
  23. ProQuest Materials Science and Engineering Database
  24. ProQuest SciTech Premium Collection
  25. ProQuest Technology Collection
  26. ProQuest-ExLibris Primo
  27. ProQuest-ExLibris Summon
  28. Reaxys
  29. SCImago
  30. SCOPUS
  31. Science Citation Index Expanded (SciSearch)
  32. TD Net Discovery Service
  33. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature